Global Nasal Spray Market, By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, and Others), Container Design (Pressurized Canisters and Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose and Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, and Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, and Others), End User (Home Care Settings, Hospitals, Clinics, and Community Health Care) – Industry Trends and Forecast to 2030.
Nasal Spray Market Analysis and Size
Nasal sprays are extensively used in respiratory diseases such as asthma patients. As per the Global Asthma Report, approximately 330 million people have asthma globally, which is anticipated to reach more than 400 million cases by 2025. It has been witnessed that the bronchodilators accounted for the largest revenue share due to their huge adoption for treating respiratory diseases, including asthma and COPD. Nasal sprays are in much higher demand yearly because of these several factors.
Data Bridge Market Research analyses that the nasal spray market, which was USD 14.4 billion in 2022, would rise to USD 24.93 billion by 2030 and is expected to undergo a CAGR of 7.10% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nasal Spray Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, and Others), Container Design (Pressurized Canisters and Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose and Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, and Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, and Others), End User (Home Care Settings, Hospitals, Clinics, and Community Health Care)
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Sandoz International GmbH (Germany), Cipla Inc (India)., Bayer AG (Germany), St. Renatus (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Leeford Healthcare Ltd (India), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Catalent, Inc. (U.S.) and Abbvie, Inc (U.S.)
Nasal sprays are a type of liquid medicines that are sprayed into the nostrils. They are used to help decrease nasal congestion. Congestion is a very common symptom of allergies or a cold. Nasal sprays are provided as over-the-counter or prescription medications. They are available in two forms, namely pressurized canisters and pump bottles. Besides the cold, it is widely used for the treatment of allergies and hay fever. It is also used to relieve sinus congestion and pressure.
Global Nasal Spray Market Dynamics
- Increasing Healthcare Expenditure For Research Activities
The increasing healthcare expenditure on nasal spray manufacturing and distribution leads to the market's growth. Additionally, increasing initiatives by public and private organizations to raise awareness about the treatment of numerous allergic reactions will enhance market growth. Several organizations are investing in top market players for the increasing production of nasal sprays. Thus, this factor boosts market growth.
- Rising Prevalence of COPD
The increasing incidence of asthma and COPD are driving the market growth as it demands high nasal spray usage. According to the records of WHO, in 2019, about 262 million people had asthma. Furthermore, as per the Asthma and Allergy Foundation of America, in 2020, 1 in every 13 people, approximately 25 million U.S. citizens, had asthma. It's been witnessed that approximately 330 million people have asthma globally, and this number is anticipated to reach more than 400 million cases by 2025. These diseases are treated with nasal sprays; thus, this factor boosts the market growth.
- Increasing Product Launches Associated with Nasal Spray
There are growing product launches by major market players expected to drive market growth. For instance, Mylan Pharmaceuticals, a Viatris Inc. subsidiary, received FDA approval for ANDA for inhalation aerosol Breyna in 2022. It is a generic version of Symbicort specifically indicated for asthma and COPD patients. This approval assists the company's objective of launching Breyna in 2022. Thus, this factor boosts market growth.
- High Role of Online Pharmacies
Online pharmacies provide ease of access and convenience to patients. With the increasing involvement of social media and online medical apps, the number of users purchasing online pharmacy products, including nasal sprays, is increasing rapidly. For instance, the number of products distributed from online pharmacies increased by around 45% from the previous year in the U.K. in 2020. Thus, this era of online pharmacies delivering nasal sprays to homes can provide great relief to patients and thus boost market growth.
- Side-Effects of Nasal Sprays
Several side effects are associated with nasal sprays that impede the market growth. Effects such as dryness and crustiness in the nose, dry, irritated throat, stinging or burning sensation in the nose, an unpleasant taste in the mouth, redness, itchiness, and swelling in the nose, nosebleeds affect the patients and thus restrict the use for nasal spray.
This nasal spray market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nasal spray market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In 2021, the U.S. Food and Drug Administration (FDA) approved a nasal antihistamine for non-prescription use through a partial prescription to a non-prescription changeover procedure. Astepro (azelastine hydrochloride nasal spray, 0.15 percent) is recommended for adults and children aged 6 years and above to treat seasonal and perennial allergic rhinitis.
Global Nasal Spray Market Scope
The nasal spray market is segmented on the basis of product type, container design, dosage form, prescription mode, therapeutic class, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Decongestion Nasal Spray
- Steroid Nasal Spray
- Salt Water Solution/ Saline Nasal Spray
- Pressurized Canisters
- Pump Bottles
- Unit/Single Dose
- Bi Dose
- Multi Dose
- Over the Counter
- Prescription Based
- Nasal Steroids
- Mast Cell Inhibitor
- Nasal Congestion
- Allergic and Non-Allergic Rhinitis
- Central Nervous System Disorders
- Home Care Settings
- Community Health Care
Nasal Spray Market Regional Analysis/Insights
The nasal spray market is analyzed and market size insights and trends are provided by product type, container design, dosage form, prescription mode, therapeutic class, application and end user as referenced above.
The countries covered in the nasal spray market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nasal spray market due to the strong economies of the U.S. and Canada, which allow major investment in new technologies. Launching several new products, acquisitions, and partnerships, and increased incidence of chronic respiratory diseases are the primary factors boosting regional growth.
Asia-Pacific is expected to witness significant growth due to major population growth, changing lifestyles, and increasing adoption of new technologies. The region's huge growth is attributed to the major partnerships to manufacture generic products in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The nasal spray market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nasal spray market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nasal spray market. The data is available for historic period 2011-2021.
Competitive Landscape and Nasal Spray Market Share Analysis
The nasal spray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nasal spray market.
Some of the major players operating in the nasal spray market are:
- Sandoz International GmbH (Germany)
- Cipla Inc (India)
- Bayer AG (Germany)
- St. Renatus (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Leeford Healthcare Ltd (India)
- Mylan N.V. (U.S.)
- Pfizer Inc. (U.S.)
- Catalent, Inc. (U.S.)
- Abbvie, Inc (U.S.)